Community-based rehab for disabilities works even in areas of conflict
A community-based rehabilitation program may be an effective way to provide services to people with disabilities even in places with conflict such as Afghanistan, finds a new study from the Brown School and the School of Medicine at Washington University.
Heiden receives award from cancer research group
Brendan Heiden, MD, a surgical resident and cardiothoracic surgery research fellow at Washington University School of Medicine, received the Harborside Endowed Merit Award from Conquer Cancer, the foundation of the American Society of Clinical Oncology.
Progression of diabetic kidney disease may be slowed with drug combinations
A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.
Suicides less common in states that passed Medicaid expansion
Researchers at Washington University School of Medicine have found that although there have been steady increases in the number of people nationwide who die by suicide, such increases have slowed in states that have implemented Medicaid expansion.
Immunity-boosting treatment enhances CAR-T cell therapy for blood cancers
A study from the Washington University School of Medicine shows that treatment with the immunity boosting protein interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells.
Gutmann elected to Association of American Physicians
David H. Gutmann, MD, PhD, the Donald O. Schnuck Family Professor of Neurology at Washington University School of Medicine, has been elected to the Association of American Physicians.
Rapid Ebola diagnosis may be possible with new technology
A new study from researchers at Washington University School of Medicine and colleagues at other institutions details a new tool that can quickly identify the presence of Ebola virus in blood samples. The technology has potential to be developed into a rapid diagnostic test.
Ruzycki receives career development award
Philip Ruzycki, an assistant professor at the School of Medicine, received a $350,000 career development award from Research to Prevent Blindness.
Lishko named BJC Investigator
Polina V. Lishko, a noted molecular biologist and entrepreneur, has been named a BJC Investigator at Washington University School of Medicine.
Researchers to study leader cells in breast cancer model
Gregory D. Longmore, MD, at the School of Medicine, and Amit Pathak, at the McKelvey School of Engineering, will study the cells that lead the migration of deadly tumor cells through the body with a five-year $2.54 million National Institutes of Health (NIH) grant.
View More Stories